Behandlingens virkning blev hovedsagelig bedømt ved den andel af patienterne, hos hvem blodets indhold af sukker og fedtstoffer igen var inden for normalom - rådet efter 12 ugers behandling.
The main measure of effectiveness was the proportion of patients whose blood glucose and fat levels had returned to within the normal range after 12 weeks of treatment.